Sinopharm-developed COVID-19 drugs to finish clinical study within a year
Two years into the pandemic, life has seen drastic changes. The death rate from overall COVID-19 infections has reached 2 percent. And pharmaceutical companies around the world are already working on drugs to combat the virus, with some making significant progress. CGTN's Liu Jiaxin talked to Zhang Yuntao, vice-president and chief scientist of the China National Biotech Group (CNBG), who shared the latest updates on China's progress toward an antiviral COVID-19 pill.